支持运动训练用于接受雄激素剥夺治疗的前列腺癌男性(STAMINA):一项随机对照试验的研究方案,评估STAMINA生活方式干预与优化常规护理相比的临床和成本效果,包括内部预试验和平行过程评估
STAMINA试验为多中心、双臂、个体随机对照试验,计划从至少12家英国NHS信托机构纳入697名接受雄激素剥夺治疗的前列腺癌男性,按5:4随机分配至STAMINA生活方式干预组(n=384)或优化常规护理组(n=313),主要结局为癌症特异性生活质量和疲劳,随访至随机化后12个月,并行过程评估和经济学评价。
要点
- 英国国家临床指南推荐接受雄激素剥夺治疗的前列腺癌男性每周接受两次监督下的有氧和抗阻运动。
- STAMINA试验旨在评估STAMINA生活方式干预相比优化常规护理在改善癌症特异性生活质量和/或减轻疲劳方面的临床和成本效果。
- 平行过程评估采用混合方法探索招募及干预的可及性、保真度、可接受性和实施情况。
核心结论
- STAMINA生活方式干预有潜力改善接受雄激素剥夺治疗的前列腺癌男性的生活质量和减轻疲劳。
- 将监督下运动嵌入前列腺癌照护可能支持长期积极行为改变并减少治疗引起的不良事件。
- 研究结果将为未来临床照护提供信息,并可能为将监督下运动和行为支持整合到其他癌症和/或临床服务提供蓝图。
研究设计与样本
- 多中心、双臂、个体随机对照试验,计划从至少12家英国NHS信托机构纳入697名接受雄激素剥夺治疗的前列腺癌男性。
- 知情同意的男性经运动安全核查后按5:4随机分配至STAMINA生活方式干预组(n=384)或优化常规护理组(n=313)。
- 结局在基线、随机化后3、6和12个月收集,两个主要结局为癌症特异性生活质量和疲劳。
- 平行过程评估采用混合方法探索招募及干预的可及性、保真度、可接受性和实施。
- 经济学评价估计STAMINA生活方式干预相比优化常规护理的成本效果,离散选择实验探索患者偏好。
临床怎么用
- 英国国家临床指南推荐接受雄激素剥夺治疗的前列腺癌男性每周接受两次监督下的有氧和抗阻运动。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: UK national clinical guidance recommends that men with prostate cancer on androgen deprivation therapy are offered twice weekly supervised aerobic and resistance exercise to address iatrogenic harm caused by treatment. Very few NHS trusts have established adequate provision of such services. Furthermore, interventions fail to demonstrate sustained behaviour change. The STAMINA lifestyle intervention offers a system-level change to clinical care delivery addressing barriers to long-term behaviour change and implementation of new prostate cancer care pathways. This trial aims to establish whether STAMINA is clinically and cost-effective in improving cancer-specific quality of life and/or reducing fatigue compared to optimised usual care. The process evaluation aims to inform the interpretation of results and, if the intervention is shown to benefit patients, to inform the implementation of the intervention into the NHS. METHODS: Men with prostate cancer on androgen deprivation therapy (n = 697) will be identified from a minimum of 12 UK NHS trusts to participate in a multi-centre, two-arm, individually randomised controlled trial. Consenting men will have a 'safety to exercise' check and be randomly allocated (5:4) to the STAMINA lifestyle intervention (n = 384) or optimised usual care (n = 313). Outcomes will be collected at baseline, 3-, 6- and 12-month post-randomisation. The two primary outcomes are cancer-specific quality of life and fatigue. The parallel process evaluation will follow a mixed-methods approach to explore recruitment and aspects of the intervention including, reach, fidelity, acceptability, and implementation. An economic evaluation will estimate the cost-effectiveness of the STAMINA lifestyle intervention versus optimised usual care and a discrete choice experiment will explore patient preferences. DISCUSSION: The STAMINA lifestyle intervention has the potential to improve quality of life and reduce fatigue in men on androgen deprivation therapy for prostate cancer. Embedding supervised exercise into prostate cancer care may also support long-term positive behaviour change and reduce adverse events caused by treatment. Findings will inform future clinical care and could provide a blueprint for the integration of supervised exercise and behavioural support into other cancer and/or clinical services. TRIAL REGISTRATION: ISRCTN 46385239, registered on 30/07/2020. Cancer Research UK 17002, retrospectively registered on 24/08/2022.
引用
- McNaught E, Reale S, Bourke L, et al. Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation. Trials. 2024. PMID: 38610058. doi:10.1186/s13063-024-07989-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。